Developer docs
API playgroundTry for free, no card

Search company profiles

The Conscious Fund

Full company profile

uuid000cg7s

Namestring
The Conscious Fund
Legal namestring
The Conscious Fund
Company typeenum
Private
Founded yearint
2018
Descriptiontext

The Conscious Fund is a private Pre-Seed and Seed-stage venture capital fund established in 2018 and headquartered in Lewes, United States. The firm invests in early-stage companies pioneering psychedelic medicine, state of mind technologies, and advanced therapeutics, and is co-founded by Henri Sant-Cassia and Michael Hoyos. Its go-to-market centers on direct outreach, network introductions within the psychedelic medicine ecosystem, and a website contact form that funnels founder, limited partner, and partnership enquiries into the firm.

The fund operates a traditional venture capital revenue model: returns accrue from capital gains on equity investments, carried interest on successful exits, and management fees on committed LP capital. Its customer base is bifurcated—founders of early-stage companies seeking Pre-Seed and Seed capital within the psychedelic and advanced therapeutics vertical, and accredited investors or institutions seeking curated exposure to that sector. Marketing and distribution are relationship-driven rather than broad-consumer oriented, consistent with a B2B investment vehicle.

The Conscious Fund is not a technology company and discloses no proprietary technology platform. Beyond core fund management, it operates the Conscious Musician Program, an educational initiative that presents research findings on awareness techniques in musical practice. With a headcount of 1–10 employees, the firm is small and concentrated on specialized deal sourcing, due diligence, and portfolio support rather than scale-driven operations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLewes, United States
HQ citystring
Lewes
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital fund, psychedelic medicine investing, early stage biotech, seed stage funding, consciousness therapeutics
Industry2 codes
1Micro-VC & Angel Funds
CodeFSANAAAIPrimaryYes
2Emerging Managers / Seeding Platforms
CodeFSAHAKAIPrimaryNo
NAICS code1 code
  • Other Investment Pools and Funds5259
Product category
Venture Capital Investment Management (Psychedelic Medicine)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Fund Management
TypeSubscription Recurring
Description

As a Pre-Seed and Seed stage investment fund established in 2018, The Conscious Fund generates returns through equity investments in early-stage companies operating in psychedelic medicine, state of mind, and advanced therapeutics. Revenue accrues from capital gains, carried interest, and management fees typical of venture capital structures.

theconscious.fund
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Conscious Fund is a Pre-Seed and Seed stage venture capital fund that invests equity capital into early-stage companies building in psychedelic medicine, state of mind, and advanced therapeutics. It also engages limited partners who commit capital to the fund and selectively partners with ecosystem collaborators. Returns are generated through equity ownership in portfolio companies plus standard fund management economics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Conscious Fund is a Pre-Seed and Seed-stage venture capital fund (established 2018) focused on investing in companies pioneering psychedelic medicine, state of mind, and advanced therapeutics. The Conscious Musician Program is an educational initiative associated with the fund's broader mission in consciousness and wellness, presenting research findings on awareness techniques in musical practice.

Product and service1 record
1Pre-Seed and Seed Equity Investment Program
CategoryVenture Capital Investment
Description

Equity capital investments made directly into early-stage companies operating in psychedelic medicine, state of mind technologies, and advanced therapeutics. Designed for founders seeking Pre-Seed or Seed funding from a sector-specialist investor.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

JLS Fund is an early-stage venture vehicle backing psychedelic and mental-health founders. It is comparable to The Conscious Fund in stage focus, thematic specialization, and LP value proposition.

TypeDirect peer
Description

Bail Capital is a venture fund that has invested in psychedelic medicine and adjacent therapeutic categories. It is a direct peer operating at early stages in overlapping theses including consciousness and mental health.

TypeBroad incumbent
Description

Founders Fund is a major US venture firm with a notable investment in Compass Pathways, signalling psychedelic-medicine exposure within a broader tech and biotech portfolio. It is a broad incumbent that competes for the same later-stage capital in the category and validates the sector for LPs.

TypeDirect peer
Description

PsyMed Ventures is an early-stage venture fund dedicated to psychedelic medicine and mental health. It is one of the closest direct peers to The Conscious Fund, deploying pre-seed/seed capital into the same category of founders with comparable check sizes and thematic focus.

TypeDirect peer
Description

Vine Ventures is a thesis-driven venture fund focused on psychedelic-assisted therapies and mental health innovation. It directly competes for the same founder pool and limited partners seeking curated psychedelic-medicine exposure.

TypeDirect peer
Description

Negev Capital is an Israel-based psychedelic medicine venture fund backing pre-clinical and clinical-stage companies globally. It is a direct peer in psychedelic VC with a comparable early-stage mandate and similar LP value proposition.

TypeDirect peer
Description

Palo Santo is a venture fund investing in psychedelic medicine and mental health companies. It shares The Conscious Fund's specialized psychedelic-medicine thesis and competes in the same deal-flow pool and LP landscape.

TypeDirect peer
Description

Beckley Waves is a psychedelic research and investment organization backing early-stage companies in psychedelic science. It is a direct peer given its shared pre-seed/seed focus on psychedelic medicine founders.

TypeDirect peer
Description

Empath Ventures is a venture fund focused on psychedelic and mental health startups at the earliest stages. Comparable in thesis, stage focus, and target founder profile to The Conscious Fund.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Conscious Fund

Venture Capital Investment Management (Psychedelic Medicine)theconscious.fund

What The Conscious Fund does

The Conscious Fund is a private Pre-Seed and Seed-stage venture capital fund established in 2018 and headquartered in Lewes, United States. The firm invests in early-stage companies pioneering psychedelic medicine, state of mind technologies, and advanced therapeutics, and is co-founded by Henri Sant-Cassia and Michael Hoyos. Its go-to-market centers on direct outreach, network introductions within the psychedelic medicine ecosystem, and a website contact form that funnels founder, limited partner, and partnership enquiries into the firm.

The fund operates a traditional venture capital revenue model: returns accrue from capital gains on equity investments, carried interest on successful exits, and management fees on committed LP capital. Its customer base is bifurcated—founders of early-stage companies seeking Pre-Seed and Seed capital within the psychedelic and advanced therapeutics vertical, and accredited investors or institutions seeking curated exposure to that sector. Marketing and distribution are relationship-driven rather than broad-consumer oriented, consistent with a B2B investment vehicle.

The Conscious Fund is not a technology company and discloses no proprietary technology platform. Beyond core fund management, it operates the Conscious Musician Program, an educational initiative that presents research findings on awareness techniques in musical practice. With a headcount of 1–10 employees, the firm is small and concentrated on specialized deal sourcing, due diligence, and portfolio support rather than scale-driven operations.

The Conscious Fund firmographics

Firmographics
Name
The Conscious Fund
Legal name
The Conscious Fund
Website
https://theconscious.fund
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

The Conscious Fund industry classification

Industry
Product category
Venture Capital Investment Management (Psychedelic Medicine)
NAICS
Other Investment Pools and Funds (5259)
akta.pro primary industry
Micro-VC & Angel Funds (FSANAAAI)
akta.pro secondary industry
Emerging Managers / Seeding Platforms (FSAHAKAI)

Keywords

  • Venture capital fund
  • Psychedelic medicine investing
  • Early stage biotech
  • Seed stage funding
  • Consciousness therapeutics

Where The Conscious Fund is headquartered

Location

Headquarters

HQ city
Lewes
HQ country
United States
HQ region
North America

Markets served

The Conscious Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Investment Fund Management: As a Pre-Seed and Seed stage investment fund established in 2018, The Conscious Fund generates returns through equity investments in early-stage companies operating in psychedelic medicine, state of mind, and advanced therapeutics. Revenue accrues from capital gains, carried interest, and management fees typical of venture capital structures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

The Conscious Fund product offering

Product offering

Core offering

The Conscious Fund is a Pre-Seed and Seed stage venture capital fund that invests equity capital into early-stage companies building in psychedelic medicine, state of mind, and advanced therapeutics. It also engages limited partners who commit capital to the fund and selectively partners with ecosystem collaborators. Returns are generated through equity ownership in portfolio companies plus standard fund management economics.

Product overview

The Conscious Fund is a Pre-Seed and Seed-stage venture capital fund (established 2018) focused on investing in companies pioneering psychedelic medicine, state of mind, and advanced therapeutics. The Conscious Musician Program is an educational initiative associated with the fund's broader mission in consciousness and wellness, presenting research findings on awareness techniques in musical practice.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pre-Seed and Seed Equity Investment Program Equity capital investments made directly into early-stage companies operating in psychedelic medicine, state of mind technologies, and advanced therapeutics. Designed for founders seeking Pre-Seed or Seed funding from a sector-specialist investor.

Companies that use The Conscious Fund

Customer profile

Segments2 records

Ideal customer profiles2 records

The Conscious Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Conscious Fund partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves3 records

Expansion highlights2 records

The Conscious Fund competitors and assessment

Company assessment

Direct peers

  • JLS Fund: JLS Fund is an early-stage venture vehicle backing psychedelic and mental-health founders. It is comparable to The Conscious Fund in stage focus, thematic specialization, and LP value proposition.
  • Bail Capital: Bail Capital is a venture fund that has invested in psychedelic medicine and adjacent therapeutic categories. It is a direct peer operating at early stages in overlapping theses including consciousness and mental health.
  • PsyMed Ventures: PsyMed Ventures is an early-stage venture fund dedicated to psychedelic medicine and mental health. It is one of the closest direct peers to The Conscious Fund, deploying pre-seed/seed capital into the same category of founders with comparable check sizes and thematic focus.
  • Vine Ventures: Vine Ventures is a thesis-driven venture fund focused on psychedelic-assisted therapies and mental health innovation. It directly competes for the same founder pool and limited partners seeking curated psychedelic-medicine exposure.
  • Negev Capital: Negev Capital is an Israel-based psychedelic medicine venture fund backing pre-clinical and clinical-stage companies globally. It is a direct peer in psychedelic VC with a comparable early-stage mandate and similar LP value proposition.
  • Palo Santo: Palo Santo is a venture fund investing in psychedelic medicine and mental health companies. It shares The Conscious Fund's specialized psychedelic-medicine thesis and competes in the same deal-flow pool and LP landscape.
  • Beckley Waves: Beckley Waves is a psychedelic research and investment organization backing early-stage companies in psychedelic science. It is a direct peer given its shared pre-seed/seed focus on psychedelic medicine founders.
  • Empath Ventures: Empath Ventures is a venture fund focused on psychedelic and mental health startups at the earliest stages. Comparable in thesis, stage focus, and target founder profile to The Conscious Fund.

Broad incumbents

  • Founders Fund: Founders Fund is a major US venture firm with a notable investment in Compass Pathways, signalling psychedelic-medicine exposure within a broader tech and biotech portfolio. It is a broad incumbent that competes for the same later-stage capital in the category and validates the sector for LPs.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights6 records

Customer concentration

The Conscious Fund social profiles

Digital presence

The Conscious Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Conscious Fund leadership team

Management profile

Number of profiles

Profiles2 records

The Conscious Fund funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Conscious Fund M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Conscious Fund

What does The Conscious Fund do?

The Conscious Fund is a Pre-Seed and Seed stage venture capital fund that invests equity capital into early-stage companies building in psychedelic medicine, state of mind, and advanced therapeutics. It also engages limited partners who commit capital to the fund and selectively partners with ecosystem collaborators. Returns are generated through equity ownership in portfolio companies plus standard fund management economics.

Is The Conscious Fund a public or private company?

The Conscious Fund is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The Conscious Fund founded?

The Conscious Fund was founded in 2018. It employs 1 to 10 people.

Where is The Conscious Fund based?

The Conscious Fund is headquartered in Lewes, United States, in the North America region.

How does The Conscious Fund make money?

One revenue line is on record: investment Fund Management.

Who are The Conscious Fund's main competitors?

Direct peers on record are JLS Fund, Bail Capital, PsyMed Ventures, Vine Ventures, Negev Capital, Palo Santo, Beckley Waves and Empath Ventures. Founders Fund is listed as a broad incumbent.

Does The Conscious Fund have an API?

No public API is recorded for The Conscious Fund.

What industry is The Conscious Fund in?

The Conscious Fund's product category is Venture Capital Investment Management (Psychedelic Medicine). Its primary akta.pro industry code is FSANAAAI, Micro-VC & Angel Funds, with a secondary code of FSAHAKAI, Emerging Managers / Seeding Platforms. Its NAICS code is 5259.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IssuewireA Virtual Investment Conference Highlighting Prominent Industry PlayersMicrodose Psychedelic Insights, in partnership with The Conscious Fund, announced the Psychedelic Capital virtual investment conference scheduled for September 30th, 2020. The conference will feature expert presentations from prominent figures in the psychedelic sector, focusing on providing investment-grade information for this emerging market. The event emphasizes the growing need for insights as the psychedelic renaissance progresses.GlobeNewswirePSYC Provides Encouraging Update on its Investment in The Conscious FundPSYC Corporation reported that its $125,000 investment in The Conscious Fund's psychedelic portfolio has gained nearly 30% unrealized as of early June 2022. The company is incorporating this data into its 2021 financial audit, which is nearing completion. PSYC CEO David Flores expressed optimism about the sector's long-term growth potential.GlobeNewswirePSYC Continues to See Strong Value Potential Tied to Its Investment in The Conscious FundGlobal Trac Solutions (PSYC) reported its $125,000 investment in The Conscious Fund (TCF) and cited progress by TCF portfolio companies, including Albert Labs, Wesana Health, Enveric Biosciences, Cybin, and Numinus Wellness. The company sees strong value potential and expects further developments in 2022.GlobeNewswireBetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of DirectorsBetterLife Pharma appointed Henri Sant-Cassia, co-founder of The Conscious Fund, to its board of directors. Sant-Cassia has 10 years of plant medicine experience and has created over $200 million in valuations within the psychedelic space. The company also announced the resignation of Sergei Stetsenko.